Tuberculosis Diagnostics Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report By 2024
“Global Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 at a substantial CAGR for the duration of the prediction.”
The global Tuberculosis Diagnostics Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: Global Tuberculosis Diagnostics Market is anticipated to reach USD 3.1 billion by 2024 owing to the introduction of enhanced diagnostic techniques like serological methods, IGRA (Interferon-gamma Release Assay), and nucleic acid testing. Tuberculosis is an infectious disorder caused by mycobacterium tuberculosis bacteria that attacks the lungs. The disorder can also spread to the other parts of the body like spine and brain. Depending on the type of tuberculosis suspected in the body, several tests are available for the diagnosis. Growth Drivers: Tuberculosis diagnostics industry is influenced by factors like quick results and improved accuracy, increasing government initiatives, growing elderly population and rising need for POC in healthcare sector. However, tuberculosis diagnostics market is restrained by significant cost of tuberculosis diagnosis and lack of awareness in patients. Additionally, the increasing burden of tuberculosis is the major factor expected to bring greater opportunities in tuberculosis diagnostics industry. Key Players: The prominent players in tuberculosis diagnostics industry include Abbott, BioMrieux SA, Hain Lifescience GmbH, Siemens, Cepheid, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, and Qiagen.
Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/tuberculosis-diagnostics-market/request-sample End-user Outlook: Based on end user, tuberculosis diagnostics industry is divided into clinics, research institutes & academics, reference laboratories, hospitals, and others. Hospital segment is predicted to register significant growth in the coming years owing to rising preference for well-organized healthcare services by patients. Test Type Outlook:
Radiographic Method
Diagnostic Laboratory Methods o
Smear Microscopy
o
Culture-based Test
Nucleic Acid Testing
Phage Assay
Detection of Latent Infection
Cytokine Detection Assay
Detection of Drug Resistance
Other Methods
Regional Outlook:
North America o U.S. o Canada Europe o UK o Russian Federation Asia Pacific o China o India Latin America o Brazil o Mexico MEA o South Africa
North America is predicted to lead the market of tuberculosis diagnostics owing to innovations in technology, approval for novel medications and increasing incidences for TB in young people. Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/
Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com
Global Headquarters
Asia Pacific
Million Insights
Million Insights
410 E Santa Clara Street,
Office No. 302, 3rd Floor, Manikchand Galleria,
Unit #1008 San Jose, CA, 95113, United States
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 1-408-610-2300 Email: sales@millioninsights.com
Phone: +91-8956380892 Email: sales@millioninsights.com